RESONIUM

This brand name is authorized in Austria, Australia, Finland, Hong Kong, Netherlands, New Zealand, Poland, United Kingdom

Active ingredients

The drug RESONIUM contains one active pharmaceutical ingredient (API):

1 Polystyrene sulfonate UNII 1699G8679Z - SODIUM POLYSTYRENE SULFONATE

Read about Polystyrene sulfonate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RESONIUM A Powder	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE01	Polystyrene sulfonate	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4470G
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 163709
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 41068
Country: HK	Department of Health Drug Office	Identifier(s): 42418
Country: NL	Z-Index G-Standaard	Identifier(s): 13650203
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 130656
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2958
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100057994